Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
| Return to All Pharma Marketing Blog Topics |
Listed in reverse chronological order:
- Merck to Vioxx Plaintiffs: Settle or Else!
- Celebrex Ad: Let's Dive Deeper
- The New Celebrex TV Ad: What Did You Learn?
- Merck Management Is "Exonerated"
- Precision Buzz Marketing
- Vioxx Scorecard: 5-3-14192
- Welcome Back Vioxx, Welcome Back
- We Were Hoodwinked!
- Merck Misled FDA According to NJ Jury
- Merck's Hand in the Cookie Jar
- Vioxx Hex or Hoax?
- Merck Changes Tactics, Lawyers Too
- Merck science "like wah, wah, wah"
- Jury as Focus Group
- Merck Found Negligent!
- Patients Come First?
- Get a Load of Those Gams!
- Cox-2's (and Pfizer?) on Slippery Slope
- Vioxx Redux
- Pharmaceutical PR: Fool Me Once, Fool Me Twice
- Cox-2's Die Hard: With a Vengeance
- Who Should Pay for Merck's Obstructionism?